APT Medical is pleased to announce that its FastMap™ HD Mapping Catheterand AForce™ Navigated Force-Sensing Ablation Catheter have received CE MDR certification, marking an important milestone in the expansion of the company's electrophysiology (EP) portfolio.

Designed for use with the HT Viewer™ Navigation System, the newly certified products enable APT Medical to provide a comprehensive 3D electrophysiology solution integrating electroanatomical mapping, EP recording, catheter navigation, and radiofrequency (RF) ablation.

At the core of the solution is the HT Viewer™ Navigation System, an electromagnetic navigation system that integrates 3D mapping, an EP recording system, and stimulation modules into a single console. By consolidating key procedural functions into one platform, the system supports an efficient electrophysiology workflow while providing comprehensive intraoperative recording and review capabilities.

Used in combination with the HT Viewer™ Navigation System, the FastMap™ HD Mapping Catheter enables rapid acquisition of cardiac geometry and high-density electrical signals, supporting efficient electroanatomical mapping during EP procedures.

The AForce™ Navigated Force-Sensing Ablation Catheter is designed to deliver precise radiofrequency ablation with real-time contact force monitoring, helping physicians optimize catheter-tissue contact during energy delivery. Its integrated force-sensing technology supports consistent lesion creation and enhanced procedural control throughout ablation procedures.

With the addition of these CE MDR-certified products, APT Medical now offers a more comprehensive electrophysiology portfolio spanning transseptal access, diagnostic mapping, 3D mapping, and radiofrequency ablation. The expanded portfolio provides physicians with an integrated solution covering key steps of the EP workflow and supports more efficient and precise cardiac ablation procedures.

CE MDR certification demonstrates compliance with the European Union Medical Device Regulation (EU MDR), one of the world's most rigorous regulatory frameworks for medical devices. This achievement reflects APT Medical's continued commitment to product quality, regulatory compliance, and clinical innovation, while reinforcing the company's ability to deliver reliable, high-quality medical technologies to healthcare professionals worldwide.

Looking ahead, APT Medical will continue to invest in research and development, expanding its electrophysiology portfolio and working closely with physicians to advance innovative technologies that improve procedural efficiency and patient care.